Dr. Paul Keown MD, DSc, MBA

Paul Keown is a specialist in immunology and transplantation, a professor in UBC’s Dept. of Medicine, and a practicing physician at Vancouver General Hospital. Dr. Keown has served as Executive Director of the BC Transplantation Program, President of the Canadian Transplantation Society and the Head of the Division of Nephrology (2004-2009). He is currently the Director of Immune Sciences, Lead for Genome Canada Transplant Consortium (2018-2025) and the Lead for the Precision Medicine in Transplantation UBC Research Excellence Cluster (2022-).

Dr. Paul Keown received his training in medicine, immunobiology and transplantation at the universities of Manchester, Paris and Western Ontario, his research doctorates in medicine and science from the University of Manchester, and his MBA from Simon Fraser University. During his decades long career his principal research activities have focused particularly on the immune response in transplantation and autoimmune disease, and extend from molecular genetics to healthcare economics.

Over his career Dr. Keown has contributed to the fields of immunopharmagology, immunogenetics, immunotherapeutics, molecular genetics and proteomics with 500+ visiting professorships, plenary addresses, or invited lectures, over 350 published abstracts and  more than 400 scientific manuscripts, editorials and book chapters.

His corporate responsibilities include Founder and Director of Syreon Corporation (N.A.) and Syreon Research Insitute (E.U.), specializing in the application of advanced information and computational sciences for personalized medicine in complex diseases. His focus is global corporate direction and strategic development; technology innovation and application, and direction of biostatistics and computational sciences.